Free Trial

Crescent Biopharma (CBIO) Institutional Ownership

Crescent Biopharma logo
$12.50 +0.28 (+2.29%)
As of 09/16/2025 04:00 PM Eastern

Institutional Ownership Changes (13F Filings) for Crescent Biopharma (NASDAQ:CBIO)

Current
Institutional Ownership
Percentage
75.19%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$61.78M
Number of
Institutional Sellers
(last 12 months)
0
Get CBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crescent Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CBIO Institutional Buying and Selling by Quarter

Crescent Biopharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Soleus Capital Management L.P.400,000$6.46M0.4%N/A2.046%
8/15/2025 Perceptive Advisors LLC453,686$7.32M0.7%N/A2.321%
8/15/2025 Frazier Life Sciences Management L.P.453,685$7.32M0.3%N/A2.321%
8/15/2025 Braidwell LP261,504$4.22M0.1%N/A1.338%
8/15/2025 BVF Inc. IL1,387,863$22.40M0.8%N/A7.099%
8/15/2025 Bank of America Corp DE9,231$149K0.0%N/A0.047%
8/15/2025 Adage Capital Partners GP L.L.C.100,912$1.63M0.0%N/A0.516%
8/14/2025 Commodore Capital LP453,686$7.32M0.5%N/A2.321%
8/13/2025 Affinity Asset Advisors LLC280,031$4.52M0.6%N/A1.432%
8/12/2025Jefferies Financial Group Inc.27,096$437K0.0%N/A0.139%
8/7/2023Acadian Asset Management LLC144,028$50K0.0%-44.5%0.381%
2/15/2023Nantahala Capital Management LLC438,055$231K0.0%-82.9%1.392%
11/10/2022Nantahala Capital Management LLC2,554,735$1.29M0.1%-7.3%8.116%
11/7/2022Virtu Financial LLC189,175$95K0.0%+250.5%0.601%
8/15/2022Nantahala Capital Management LLC2,755,903$4.91M0.2%+13.8%8.755%
8/13/2022Virtu Financial LLC53,977$96K0.0%N/A0.171%
2/10/2022Acadian Asset Management LLC232,400$211K0.0%N/A0.740%
2/8/2022Raymond James & Associates32,800$30K0.0%-74.7%0.104%
2/1/2022Assenagon Asset Management S.A.512,643$469K0.0%N/A1.632%
11/16/2021Squarepoint Ops LLC25,527$105K0.0%-45.8%0.081%
11/16/2021Two Sigma Advisers LP107,000$440K0.0%-30.0%0.341%
11/16/2021Millennium Management LLC671,224$2.76M0.0%-14.8%2.140%
11/15/2021Pura Vida Investments LLC372,582$1.53M0.0%N/A1.188%
11/15/2021Dimensional Fund Advisors LP801,440$3.29M0.0%-13.4%2.555%
11/15/2021GSA Capital Partners LLP175,751$722K0.1%+3.7%0.560%
11/12/2021Johnson & Johnson66,951$275K0.0%N/A0.213%
11/12/2021Parkman Healthcare Partners LLC133,449$548K0.1%-66.1%0.425%
11/12/2021Stonepine Capital Management LLC2,635,014$10.83M4.9%-14.3%8.401%
11/12/2021Geode Capital Management LLC351,541$1.44M0.0%+5.7%1.121%
11/10/2021Goldman Sachs Group Inc.160,701$660K0.0%-38.4%0.512%
11/9/2021BlackRock Inc.270,718$1.11M0.0%-4.3%0.863%
11/2/2021Raymond James & Associates129,553$532K0.0%-4.1%0.413%
11/1/2021Cherry Creek Investment Advisors Inc.20,000$82K0.1%N/A0.064%
10/29/2021Commonwealth Equity Services LLC10,000$41K0.0%N/A0.032%
9/3/2021Parametric Portfolio Associates LLC21,019$91K0.0%-51.9%0.067%
8/19/2021M Holdings Securities Inc.85,202$369K0.0%-9.6%0.272%
8/17/2021Millennium Management LLC787,748$3.41M0.0%+46.1%2.511%
8/17/202122NW LP1,429,242$6.19M1.7%+84.4%4.557%
8/17/2021Acuta Capital Partners LLC685,000$2.97M1.2%-27.1%2.184%
8/16/2021Squarepoint Ops LLC47,060$204K0.0%-32.6%0.150%
8/16/2021PDT Partners LLC11,794$51K0.0%-78.6%0.038%
8/16/2021Nantahala Capital Management LLC2,531,360$10.96M0.3%-1.2%8.070%
8/16/2021Schonfeld Strategic Advisors LLC94,800$411K0.0%+11.0%0.302%
8/16/2021Charles Schwab Investment Management Inc.13,113$57K0.0%-83.3%0.042%
8/16/2021State Street Corp43,399$188K0.0%-88.5%0.138%
8/16/2021Tibra Equities Europe Ltd79,200$343K0.1%N/A0.253%
8/16/2021Tocqueville Asset Management L.P.54,580$236K0.0%+37.9%0.174%
8/13/2021Renaissance Technologies LLC448,197$1.94M0.0%N/A1.429%
8/13/2021Northern Trust Corp106,943$463K0.0%-68.2%0.341%
8/13/2021Geode Capital Management LLC332,479$1.44M0.0%-37.8%1.060%
8/13/2021Vanguard Group Inc.1,422,331$6.16M0.0%-7.2%4.535%
8/12/2021Trexquant Investment LP32,220$140K0.0%N/A0.103%
8/12/2021XTX Topco Ltd15,265$66K0.0%N/A0.049%
8/12/2021Dimensional Fund Advisors LP925,706$4.01M0.0%+2.0%2.951%
8/12/2021Advisory Services Network LLC19,700$85K0.0%N/A0.063%
8/12/2021Stephens Inc. AR16,885$73K0.0%+64.6%0.054%
8/12/2021JPMorgan Chase & Co.84,996$368K0.0%-33.1%0.271%
8/12/2021Bank of Montreal Can212,398$971K0.0%+36.5%0.677%
8/12/2021Ergoteles LLC108,500$470K0.0%N/A0.346%
8/11/2021Bank of New York Mellon Corp75,309$326K0.0%-44.8%0.240%
8/11/2021Quantitative Systematic Strategies LLC16,277$70K0.0%-45.7%0.052%
8/11/2021Deutsche Bank AG194,933$844K0.0%-26.5%0.622%
(Data available from 1/1/2016 forward)

CBIO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CBIO shares?

During the previous two years, 10 institutional investors and hedge funds held shares of Crescent Biopharma. The most heavily invested institutionals were BVF Inc. IL ($22.40M), Frazier Life Sciences Management L.P. ($7.32M), Perceptive Advisors LLC ($7.32M), Commodore Capital LP ($7.32M), Soleus Capital Management L.P. ($6.46M), Affinity Asset Advisors LLC ($4.52M), and Braidwell LP ($4.22M).Learn more on Crescent Biopharma's institutional investors.

What percentage of Crescent Biopharma's stock is owned by institutional investors?

75.19% of Crescent Biopharma's stock is owned by institutional investors. Learn more on CBIO's institutional investor holdings.

Which institutional investors have been buying Crescent Biopharma's stock?

Of the 10 institutional investors that purchased Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($1.39M), Commodore Capital LP ($453.69K), Perceptive Advisors LLC ($453.69K), Frazier Life Sciences Management L.P. ($453.69K), Soleus Capital Management L.P. ($400K), Affinity Asset Advisors LLC ($280.03K), and Braidwell LP ($261.50K).

How much institutional buying is happening at Crescent Biopharma?

Institutional investors have bought a total of 3,827,694 shares in the last 24 months. This purchase volume represents approximately $61.78M in transactions.



This page (NASDAQ:CBIO) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners